Advertisement
Advertisement
U.S. Markets open in 1 hr 20 mins
S&P Futures
4,028.00 +26.75 (+0.67%) Dow Futures
32,648.00 +214.00 (+0.66%) Nasdaq Futures
12,941.00 +50.75 (+0.39%) Russell 2000 Futures
1,768.60 +20.90 (+1.20%) Crude Oil
70.23 +0.97 (+1.40%) Gold
1,955.10 -28.70 (-1.45%)
Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 31.45 |
| Open | 31.24 |
| Bid | 0.00 x 800 |
| Ask | 32.49 x 1100 |
| Day's Range | 30.20 - 32.09 |
| 52 Week Range | 11.27 - 36.61 |
| Volume | |
| Avg. Volume | 1,617,411 |
| Market Cap | 2.608B |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.86 |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 35.08 |
- Business Wire
Revance to Participate in Upcoming Investor Conferences
NASHVILLE, Tenn., March 07, 2023--Revance to Participate in Upcoming Investor Conferences
- Insider Monkey
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2022 Earnings Call Transcript
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following managements’ prepared remarks, we will hold a Q&A session. As a reminder, this […]
- Thomson Reuters StreetEvents
Q4 2022 Revance Therapeutics Inc Earnings Call
Q4 2022 Revance Therapeutics Inc Earnings Call
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
